Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 142,241,456
  • Shares Outstanding, K 5,666,990
  • Annual Sales, $ 58,496 M
  • Annual Income, $ 2,119 M
  • EBIT $ 10,649 M
  • EBITDA $ 16,939 M
  • 60-Month Beta 0.67
  • Price/Sales 2.41
  • Price/Cash Flow 8.35
  • Price/Book 1.52

Options Overview Details

View History
  • Implied Volatility 27.11% ( +1.88%)
  • Historical Volatility 22.56%
  • IV Percentile 69%
  • IV Rank 61.58%
  • IV High 32.70% on 04/12/24
  • IV Low 18.16% on 05/13/24
  • Put/Call Vol Ratio 0.59
  • Today's Volume 161,218
  • Volume Avg (30-Day) 206,588
  • Put/Call OI Ratio 0.87
  • Today's Open Interest 3,332,029
  • Open Int (30-Day) 3,053,468

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.52
  • Number of Estimates 7
  • High Estimate 0.65
  • Low Estimate 0.39
  • Prior Year 0.10
  • Growth Rate Est. (year over year) +420.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.48 +1.88%
on 11/15/24
29.22 -14.65%
on 10/21/24
-4.28 (-14.65%)
since 10/18/24
3-Month
24.48 +1.88%
on 11/15/24
30.43 -18.04%
on 10/09/24
-3.96 (-13.70%)
since 08/20/24
52-Week
24.48 +1.88%
on 11/15/24
31.54 -20.93%
on 07/30/24
-5.04 (-16.81%)
since 11/20/23

Most Recent Stories

More News
5 Year-to-Date Laggards to Buy Amid Solid Near-Term Upside Potential

U.S. stock markets have been witnessing an impressive rally since the beginning of 2023 barring some minor hurdles. Wall Street’s bull run has got an added boost this year, to the surprise of a large...

DG : 73.27 (-4.22%)
ADBE : 499.50 (-0.02%)
SNAP : 10.59 (+0.76%)
RYAAY : 43.94 (-2.40%)
PFE : 24.94 (-0.64%)
Is It Time to Sell Eli Lilly and Pfizer Stocks?

Arguably, no big pharma stocks have dominated the industry more over the last few years than Eli Lilly (NYSE: LLY) and Pfizer (NYSE: PFE) .

LLY : 753.41 (+3.25%)
PFE : 24.94 (-0.64%)
The Zacks Analyst Blog Highlights Pfizer, Newmont, Uber, Adobe and Qualcomm

For Immediate ReleaseChicago, IL – November 19, 2024 – Zacks.com announces the list of Stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and...

QCOM : 154.27 (-6.34%)
NEM : 42.99 (-0.44%)
ADBE : 499.50 (-0.02%)
UBER : 69.60 (+0.68%)
PFE : 24.94 (-0.64%)
TAHO Pharmaceuticals Initiates U.S. Phase III Clinical Trial of TAH3311 Antithrombotic Oral Dissolving Film, Dosing First Subjects

/CNW/ -- TAHO Pharmaceuticals Ltd. announced the dosing of the first subjects in its U.S. Phase III clinical trial for its lead product, TAH3311, an innovative...

PFE : 24.94 (-0.64%)
Top Analyst Reports for Thermo Fisher, NextEra Energy & Lowe's

Monday, November 18, 2024The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher...

SHOP : 103.94 (-0.62%)
LOW : 263.03 (+1.45%)
TMO : 512.84 (+0.73%)
SCHW : 80.46 (+0.34%)
PFE : 24.94 (-0.64%)
NEE : 76.88 (-0.26%)
Stock market today: Wall Street rises following last week's slide

Most U.S. stocks ticked higher to recover some of their sharp slide from last week

NVDA : 145.89 (-0.76%)
CVS : 56.83 (+1.90%)
LOW : 263.03 (+1.45%)
$SPX : 5,917.11 (unch)
$DOWI : 43,408.47 (+0.32%)
SAVE : 1.0200 (-5.56%)
LBRT : 17.57 (+1.27%)
MRNA : 36.94 (-0.94%)
$IUXX : 20,667.10 (-0.08%)
PFE : 24.94 (-0.64%)
FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria

Sanofi SNY and partner Regeneron REGN announced that the FDA has accepted their resubmitted supplemental biologics license application (sBLA) seeking approval of Dupixent for the treatment of chronic spontaneous...

GILD : 88.63 (+1.00%)
REGN : 743.35 (-0.17%)
PFE : 24.94 (-0.64%)
SNY : 47.78 (-0.46%)
Buy 5 U.S. Bigwigs on the Dip for Sparkling Returns in the Short Term

U.S. stock markets, in all likelihood, are set to close a solid 2024 after an impressive 2023. Although most of the rally has been driven by an unprecedented adoption of generative artificial intelligence...

QCOM : 154.27 (-6.34%)
NEM : 42.99 (-0.44%)
ADBE : 499.50 (-0.02%)
UBER : 69.60 (+0.68%)
PFE : 24.94 (-0.64%)
2 High-Yield Dividend Stocks I Can't Stop Buying

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible Trump-era tariffs could complicate the Fed's plans, several blue-chip dividend...

MO : 55.98 (+0.21%)
T : 22.83 (+0.44%)
PM : 130.39 (+0.66%)
PFE : 24.94 (-0.64%)
Stocks Set to Open Mixed as Investors Await U.S. Economic Data and Nvidia Earnings, Fed Speak on Tap

December S&P 500 E-Mini futures (ESZ24) are down -0.14%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.12% this morning as market participants looked ahead to an earnings report from semiconductor...

TGT : 121.72 (-21.41%)
AMAT : 170.49 (+0.70%)
NVDA : 145.89 (-0.76%)
DE : 404.96 (+1.22%)
TJX : 119.74 (+0.15%)
INTU : 650.60 (+1.00%)
SNOW : 129.12 (-0.86%)
SMCI : 25.80 (-8.74%)
NQZ24 : 20,669.25 (-0.38%)
MRO.LN : 493.700 (-1.50%)
PFE : 24.94 (-0.64%)
ASTS : 23.58 (-9.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 25.59
2nd Resistance Point 25.35
1st Resistance Point 25.14
Last Price 24.94
1st Support Level 24.69
2nd Support Level 24.45
3rd Support Level 24.24

See More

52-Week High 31.54
Fibonacci 61.8% 28.84
Fibonacci 50% 28.01
Fibonacci 38.2% 27.18
Last Price 24.94
52-Week Low 24.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar